Abstract
Adverse reactions to iodinated contrast media are varied and known to develop in patients with asthma and a history of allergy. We describe three successful allogeneic bone marrow transplantation (BMT) patients, who all developed dermal graft-versus-host disease (GVHD) after receiving contrast media. Cutaneous GVHD triggered by contrast media has not been reported to date and has implications for the assessment, monitoring and treatment of patients during the post-transplant period.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ruutu T, Volin L, Elonen E . Low incidence of severe acute and chronic graft-versus-host disease as a result of prolonged cyclosporine prophylaxis and early aggressive treatment with corticosteroids Transplant Proc 1988 20: 491 493
Lonnqvist B, Aschan J, Ljungman P, Ringden O . Long-term cyclosporin therapy may decrease the risk of chronic graft-versus-host disease Br J Haematol 1990 74: 547 548
Bacigalupo A, Maiolino A, Van Lint MT et al. Cyclosporin A and chronic graft-versus-host disease Bone Marrow Transplant 1990 6: 341 344
De Gast GC, Beatty PG, Amos D et al. Transfusions shortly before HLA-matched marrow transplantation for leukemia are associated with a decrease in chronic graft-versus-host disease Bone Marrow Transplant 1991 7: 293 295
Bolger GB, Sullivan KM, Storb R et al. Second marrow infusion for poor graft function after allogeneic marrow transplantation Bone Marrow Transplant 1986 1: 21 30
Bostrom L, Ringden O, Jacobsen N et al. A European multicenter study of chronic graft-versus-host disease. The role of cytomegalovirus serology in recipients and donors, acute graft-versus-host disease, and splenectomy Transplantation 1990 49: 1100 1105
Przepiorka D, Kernan C, Ippoliti C et al. Daclizumab, a humanized anti-interleukin-2-receptor alpha chain antibody, for treatment of acute graft-versus-host disease Blood 2000 95: 83 89
Grundy JE, Shanley JD, Shearer GM . Augmentation of graft-versus-host reaction by cytomegalovirus infection resulting in interstitial pneumonitis Transplantation 1985 39: 548 553
Samson D, Volin L, Schanz U et al. Feasibility and toxicity of interferon maintenance therapy after allogeneic BMT for multiple myeloma : a pilot study of the EBMT Bone Marrow Transplant 1996 17: 759 762
Christiansen C, Pichler WJ, Skotland T . Delayed allergy-like reactions to X-ray contrast media: mechanistic considerations Eur Radiol 2000 10: 1965 1975
Yoshikawa H . Late adverse reactions to non-ionic contrast media Radiology 1992 183: 737 740
Almen T . The etiology of contrast medium reactions Invest Radiol 1994 29: (Suppl.) S37 S45
Zhou Y, Barnett MJ, Rivers JK . Clinical significance of skin biopsies in the diagnosis and management of graft-versus-host disease in early postallogeneic bone marrow transplantation Arch Dermatol 2000 136: 717 721
Barbaud A, Bene MC, Faure G . Immunological physiopathology of cutaneous adverse drug reactions Eur J Dermatol 1997 7: 319 323
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vavricka, S., Halter, J., Furrer, K. et al. Contrast media triggering cutaneous graft-versus-host disease. Bone Marrow Transplant 29, 899–901 (2002). https://doi.org/10.1038/sj.bmt.1703564
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703564
Keywords
This article is cited by
-
Late adverse reactions to intravascular iodine based contrast media: an update
European Radiology (2011)